Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of “Buy” from Analysts
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage on the […]
More Stories
Tactile Systems Technology (NASDAQ: TCMD) Appoints Laura G. King to Board of Directors
Tactile Systems Technology, Inc. recently announced the election of Laura G. King to its board of directors on January 10,...
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Receives “Outperform” Rating from Wedbush
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Wedbush in a research report issued...
Wearable Devices Ltd. (NASDAQ:WLDS) Sees Large Decline in Short Interest
Wearable Devices Ltd. (NASDAQ:WLDS – Get Free Report) was the recipient of a significant decline in short interest in December....
Stratus Properties (NASDAQ:STRS) Share Price Crosses Below 200 Day Moving Average – Should You Sell?
Stratus Properties Inc. (NASDAQ:STRS – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday...
LightInTheBox (NYSE:LITB) Share Price Passes Below Two Hundred Day Moving Average – What’s Next?
LightInTheBox Holding Co., Ltd. (NYSE:LITB – Get Free Report) shares passed below its two hundred day moving average during trading...
H2O Innovation (CVE:HEO) Share Price Passes Below 200 Day Moving Average – What’s Next?
H2O Innovation Inc. (CVE:HEO – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday...